Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exercise | 14 | 2022 | 603 | 1.440 |
Why?
|
| Mobility Limitation | 10 | 2019 | 208 | 1.370 |
Why?
|
| Exercise Therapy | 7 | 2022 | 250 | 1.120 |
Why?
|
| Accidental Falls | 4 | 2016 | 104 | 1.010 |
Why?
|
| Health Education | 10 | 2019 | 149 | 0.970 |
Why?
|
| Aged | 35 | 2023 | 10260 | 0.760 |
Why?
|
| Aged, 80 and over | 25 | 2018 | 3898 | 0.660 |
Why?
|
| Disabled Persons | 5 | 2018 | 100 | 0.620 |
Why?
|
| Geriatric Assessment | 7 | 2018 | 335 | 0.590 |
Why?
|
| Muscle Strength | 5 | 2023 | 135 | 0.550 |
Why?
|
| Food Services | 2 | 2015 | 19 | 0.540 |
Why?
|
| Aspirin | 4 | 2022 | 59 | 0.510 |
Why?
|
| Disability Evaluation | 4 | 2018 | 242 | 0.500 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2014 | 75 | 0.490 |
Why?
|
| Geriatrics | 2 | 2014 | 86 | 0.490 |
Why?
|
| Female | 36 | 2022 | 19942 | 0.480 |
Why?
|
| Male | 33 | 2022 | 19437 | 0.470 |
Why?
|
| Motor Activity | 4 | 2015 | 332 | 0.430 |
Why?
|
| Body Mass Index | 5 | 2016 | 863 | 0.420 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2018 | 79 | 0.410 |
Why?
|
| Humans | 40 | 2023 | 32274 | 0.410 |
Why?
|
| Risk Assessment | 3 | 2015 | 1425 | 0.400 |
Why?
|
| Walking | 6 | 2019 | 200 | 0.390 |
Why?
|
| Aging | 6 | 2017 | 942 | 0.380 |
Why?
|
| Single-Blind Method | 8 | 2018 | 192 | 0.370 |
Why?
|
| Primary Health Care | 1 | 2014 | 232 | 0.360 |
Why?
|
| Health Promotion | 3 | 2015 | 242 | 0.350 |
Why?
|
| Obesity | 5 | 2016 | 1111 | 0.330 |
Why?
|
| United States | 11 | 2018 | 4072 | 0.310 |
Why?
|
| Risk Reduction Behavior | 3 | 2017 | 117 | 0.280 |
Why?
|
| Dietary Supplements | 2 | 2023 | 188 | 0.280 |
Why?
|
| Risk Factors | 8 | 2022 | 3934 | 0.270 |
Why?
|
| Cognition | 2 | 2017 | 547 | 0.270 |
Why?
|
| Adipose Tissue | 3 | 2016 | 320 | 0.260 |
Why?
|
| Frail Elderly | 1 | 2018 | 69 | 0.260 |
Why?
|
| Hand Strength | 2 | 2015 | 98 | 0.260 |
Why?
|
| Life Style | 5 | 2022 | 393 | 0.250 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 1158 | 0.220 |
Why?
|
| Ankle Brachial Index | 1 | 2015 | 38 | 0.220 |
Why?
|
| Motor Skills Disorders | 1 | 2014 | 7 | 0.210 |
Why?
|
| Forced Expiratory Volume | 1 | 2014 | 81 | 0.210 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 34 | 0.210 |
Why?
|
| Hemorrhage | 3 | 2018 | 95 | 0.200 |
Why?
|
| Australia | 4 | 2022 | 35 | 0.200 |
Why?
|
| Hospitalization | 1 | 2016 | 475 | 0.190 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 478 | 0.190 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2013 | 52 | 0.190 |
Why?
|
| Vitamin D Deficiency | 1 | 2023 | 87 | 0.180 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 520 | 0.170 |
Why?
|
| Mortality | 2 | 2018 | 122 | 0.170 |
Why?
|
| Muscles | 2 | 2023 | 69 | 0.170 |
Why?
|
| Cholecalciferol | 2 | 2023 | 25 | 0.160 |
Why?
|
| Cognition Disorders | 1 | 2013 | 349 | 0.160 |
Why?
|
| Vitamins | 2 | 2023 | 71 | 0.160 |
Why?
|
| Fatigue | 1 | 2019 | 76 | 0.150 |
Why?
|
| Independent Living | 4 | 2018 | 90 | 0.150 |
Why?
|
| Cross-Sectional Studies | 4 | 2016 | 1479 | 0.140 |
Why?
|
| Lower Extremity | 2 | 2016 | 100 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2017 | 1437 | 0.140 |
Why?
|
| Oxygen Consumption | 3 | 2015 | 141 | 0.140 |
Why?
|
| Actigraphy | 1 | 2017 | 15 | 0.140 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 324 | 0.130 |
Why?
|
| Personal Satisfaction | 1 | 2008 | 28 | 0.130 |
Why?
|
| Diet, Reducing | 2 | 2009 | 85 | 0.130 |
Why?
|
| Environment Design | 1 | 2016 | 15 | 0.130 |
Why?
|
| Educational Measurement | 2 | 2014 | 113 | 0.120 |
Why?
|
| Dementia | 2 | 2018 | 246 | 0.120 |
Why?
|
| Health Status | 1 | 2008 | 355 | 0.120 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 140 | 0.120 |
Why?
|
| Homebound Persons | 1 | 2015 | 9 | 0.110 |
Why?
|
| Executive Function | 1 | 2015 | 52 | 0.110 |
Why?
|
| Residence Characteristics | 1 | 2016 | 178 | 0.110 |
Why?
|
| Mitochondria, Muscle | 1 | 2015 | 18 | 0.110 |
Why?
|
| Quality of Life | 3 | 2018 | 964 | 0.110 |
Why?
|
| Gait | 3 | 2017 | 120 | 0.110 |
Why?
|
| Double-Blind Method | 3 | 2023 | 565 | 0.110 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 94 | 0.110 |
Why?
|
| Clinical Competence | 2 | 2014 | 330 | 0.110 |
Why?
|
| Heart Rate | 1 | 2016 | 362 | 0.110 |
Why?
|
| Weight Loss | 2 | 2009 | 410 | 0.110 |
Why?
|
| Pilot Projects | 3 | 2015 | 553 | 0.110 |
Why?
|
| Minority Health | 1 | 2014 | 5 | 0.100 |
Why?
|
| Treatment Failure | 3 | 2018 | 165 | 0.100 |
Why?
|
| Home Care Services | 1 | 2014 | 51 | 0.100 |
Why?
|
| Religion and Medicine | 1 | 2014 | 18 | 0.100 |
Why?
|
| Administration, Oral | 3 | 2018 | 200 | 0.100 |
Why?
|
| North Carolina | 2 | 2014 | 1300 | 0.100 |
Why?
|
| Age Factors | 4 | 2017 | 1179 | 0.100 |
Why?
|
| Models, Educational | 1 | 2013 | 20 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2016 | 458 | 0.100 |
Why?
|
| Health Behavior | 1 | 2014 | 211 | 0.090 |
Why?
|
| African Americans | 2 | 2016 | 1335 | 0.090 |
Why?
|
| Postmenopause | 2 | 2010 | 424 | 0.080 |
Why?
|
| Adipokines | 1 | 2010 | 11 | 0.080 |
Why?
|
| Muscle Weakness | 1 | 2010 | 34 | 0.080 |
Why?
|
| Body Composition | 2 | 2009 | 327 | 0.080 |
Why?
|
| Postural Balance | 2 | 2016 | 142 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2018 | 3416 | 0.070 |
Why?
|
| Abdominal Fat | 1 | 2009 | 39 | 0.070 |
Why?
|
| Kidney | 1 | 2022 | 521 | 0.070 |
Why?
|
| Vitamin D | 2 | 2023 | 186 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2018 | 171 | 0.070 |
Why?
|
| Time Factors | 3 | 2017 | 2204 | 0.060 |
Why?
|
| Waist Circumference | 1 | 2016 | 91 | 0.060 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 37 | 0.060 |
Why?
|
| Adipocytes | 1 | 2006 | 69 | 0.060 |
Why?
|
| Resistance Training | 2 | 2016 | 58 | 0.060 |
Why?
|
| Incidence | 2 | 2018 | 1241 | 0.050 |
Why?
|
| Spirometry | 1 | 2014 | 25 | 0.050 |
Why?
|
| Middle Aged | 6 | 2016 | 11848 | 0.050 |
Why?
|
| Risk | 1 | 2014 | 305 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 2240 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2013 | 174 | 0.050 |
Why?
|
| Prognosis | 2 | 2017 | 1534 | 0.050 |
Why?
|
| Glucose Tolerance Test | 2 | 2016 | 126 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2013 | 179 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 541 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2013 | 1840 | 0.040 |
Why?
|
| Adult | 3 | 2016 | 9256 | 0.040 |
Why?
|
| Adolescent | 2 | 2016 | 3517 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 76 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 236 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2008 | 74 | 0.030 |
Why?
|
| Leisure Activities | 1 | 2016 | 16 | 0.030 |
Why?
|
| Pulse | 1 | 2016 | 9 | 0.030 |
Why?
|
| Rest | 1 | 2016 | 48 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 327 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 245 | 0.030 |
Why?
|
| Muscle Stretching Exercises | 1 | 2015 | 5 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 188 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 245 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 388 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 883 | 0.030 |
Why?
|
| Upper Extremity | 1 | 2015 | 68 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2016 | 205 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 316 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 308 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 2316 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2014 | 12 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 274 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 543 | 0.030 |
Why?
|
| Sex Factors | 1 | 2016 | 655 | 0.030 |
Why?
|
| Health Surveys | 1 | 2014 | 175 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 821 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 471 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 861 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2016 | 1076 | 0.020 |
Why?
|
| Curriculum | 1 | 2013 | 203 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 754 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 224 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 2648 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 215 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 90 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2009 | 92 | 0.020 |
Why?
|
| Overweight | 1 | 2009 | 252 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2009 | 484 | 0.020 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2006 | 12 | 0.010 |
Why?
|
| Cell Size | 1 | 2006 | 40 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 555 | 0.010 |
Why?
|